Physicians' Academy for Cardiovascular Education

Latest frontiers in anticoagulation therapy

Meeting report with video, highlights and slides of PACE-CME live webcast held at January 12, 2018

Meeting Impression | Latest frontiers in anticoagulation therapy

EBAC accredited session held on January 12, 2018
EBAC accredited session held on January 12, 2018

In this live webcast, recent clinical evidence on NOACs/DOACs in patients with both AF and VTE were summarized.

Appropriate use of NOACs: What is the state of the art for 2018?

Latest frontiers in anticoagulation therapy (4/4)

15' education - Feb. 20, 2018 - Prof. John Eikelboom, McMaster University, Hamilton, Ontario, Canada
Prof. John Eikelboom discusses current choices of OACs and management of patients who receive a NOAC

Latest frontiers in anticoagulation therapy Prof. John Eikelboom discusses current choices of OACs and management of patients who receive a NOAC

Practical guidance on NOACs and safety: How to deal with challenging situations in AF

Latest frontiers in anticoagulation therapy (3/4)

15' education - Feb. 20, 2018 - Prof. John Eikelboom - Hamilton, ON, Canada
Prof. John Eikelboom discusses the indications for reversal of anticoagulation and results of trials with the available reversal agents.

Latest frontiers in anticoagulation therapy Prof. John Eikelboom discusses the indications for reversal of anticoagulation and results of trials with the available reversal agents.

Anticoagulation 2017: The key lessons and implications from recent clinical trials (2)

Latest frontiers in anticoagulation therapy (2/4)

15' education - Jan. 12, 2018 - Prof. John Eikelboom - Hamilton, ON, Canada
Prof. John Eikelboom summarizes results from COMPASS / Hokusai VTE Cancer trials and discusses the implications for clinical practice

Latest frontiers in anticoagulation therapy Prof. John Eikelboom summarizes results from COMPASS / Hokusai VTE Cancer trials and discusses the implications for clinical practice.

Anticoagulation 2017: The key lessons and implications from recent clinical trials (1)

Latest frontiers in anticoagulation therapy (1/4)

15' education - Jan. 12, 2018 - Prof. John Eikelboom - Hamilton, ON, Canada
Prof. John Eikelboom summarizes results from RE-CIRCUIT / RE-DUAL PCI trials and discusses the implications for clinical practice

Latest frontiers in anticoagulation therapy Prof. John Eikelboom summarizes results from RE-CIRCUIT / RE-DUAL PCI trials and discusses the implications for clinical practice.

15' Education

Appropriate use of NOACs: What is the state of the art for 2018?

15' education - Feb. 20, 2018 - Prof. John Eikelboom, McMaster University, Hamilton, Ontario, Canada

Practical guidance on NOACs and safety: How to deal with challenging situations in AF

15' education - Feb. 20, 2018 - Prof. John Eikelboom - Hamilton, ON, Canada

Anticoagulation 2017: The key lessons and implications from recent clinical trials (2)

15' education - Jan. 12, 2018 - Prof. John Eikelboom - Hamilton, ON, Canada

Anticoagulation 2017: The key lessons and implications from recent clinical trials (1)

15' education - Jan. 12, 2018 - Prof. John Eikelboom - Hamilton, ON, Canada

Presentation Slides

Slides: Appropriate use of NOACs: What is the state of the art for 2018?

Slides (presentation) - Feb. 20, 2018 - Prof. John Eikelboom, McMaster University, Ontario, Canada

Slides: Practical guidance on NOACs and safety: How to deal with challenging situations in AF

Slides (presentation) - Feb. 20, 2018 - Prof. John Eikelboom, McMaster University, Ontario, Canada

Slides: Anticoagulation 2017: The key lessons and implications from COMPASS / Hokusai VTE Cancer

Slides (presentation) - Feb. 20, 2018 - Prof. John Eikelboom - Hamilton, ON, Canada

Slides: Anticoagulation 2017: The key lessons and implications from RE-CIRCUIT / RE-DUAL PCI

Slides (presentation) - Jan. 12, 2018 - Prof. John Eikelboom, McMaster University, Ontario, Canada